Tag: I2Cure

News

I2Cure in Association with MyGate Commences ‘Breaking the Pandemic Chain’ Movement by Introducing its BioShield to 15,000 Societies

Dec 21, 2020 by Rekha Nair 0 Comments #COO & Co-founder, #Director - Marketing Strategy & Distribution, #I2Cure, #Mr. Abhishek Kumar, #MyGate, #Ramesh Menon

National: I2Cure has collaborated with MyGate to secure its 15,000 gated communities against the pandemic spread. I2cure’s patented BioShield™ Antiseptic Lotion, a single-use, broad-spectrum antimicrobial that offers the protection of iodine against COVID-19 for six hours at a stretch, is a significant step up from existing alcohol-based solutions, which are merely disinfectants. While the global launch of I2Cure’s solution is planned in January 2021, MyGate, recognizing the superficial nature of disinfectants and their limited usefulness, is bringing this state-of-the-art solution to all its societies across India ahead of time. The collaboration will see MyGate assisting gated communities to strengthen their protection against the virus with I2Cure Bioshield.

Ramesh Menon, Director – Marketing Strategy & Distribution, I2Cure, says, “Our product is currently the most effective COVID-19 preventive available to the masses, and we are happy to partner with MyGate to bring it to the gates of its 15,000 communities, to ensure the safety of the millions that reside therein as well as the millions of people, from daily help to delivery executives, that visit them on a daily basis.”

Elaborating on the initiative, Mr. Abhishek Kumar, COO & Co-founder, MyGate, says, “With the MyGate collaboration, gated communities can now get direct access to I2Cure BioShield™. It is a matter of pride for us to enable this for our communities, who, in turn, have already shown strong interest in using the product to break the transmission chain. This movement has the potential to dramatically slow down the spread of virus in urban India.”

With education institutions and offices closed and public transport drastically reduced, gated communities are among the most active congregations and remain potential hotspots for the virus. The majority of housing societies are taking numerous precautions – ensuring that visitors and staff wear masks, running a temperature check at the entry point – but virus transmission via surface remains a major concern. With the BioShield™, housing societies can protect themselves from this risk to a great extent, enabling life to return to near normal within the society.

While sanitizers offer protection only on application, BioShield’s molecular iodine solution percolates under the skin, acting as a shield against any virus and germs for six hours at a time. With a single application at the gate or at their homes residents can be protected from the possibility of being infected by the virus.  This will result in a significant drop in the potential number of virus carriers and breaking the chain of pandemic transmission. I2cure has been tested and certified effective by Intertek labs USA. The product’s development has been guided by Dr. Jack Kessler, whose more than 2-decade-old research into molecular iodine has led to several advancements in the field and the successful development of I2Cure without the negative characteristics of staining, irritation, toxicity and the risk of acidosis. In addition to a global launch, I2cure is currently in discussion with public health bodies for mass distribution of the BioShield™.

During the pandemic, MyGate has introduced a number of new features and inked partnerships to enhance the safety of the 2.5 million families that reside in its communities.

Business World

I2cure BioShield proven 99.9% effective against coronavirus: US Based laboratory proclaims

Oct 19, 2020 by Gouri Achary 0 Comments #Dr. Jack Kessler (Father of I2), #Dr. Kessler, #I2Cure, #I2cure BioShield

In the time of the global pandemic, I2cure launched their BioShield in India which is a research of Dr. Jack Kessler (Father of I2) an FDA Compliant, ISO 9001:2015, and WHO GMP certified product. Recently, a study was conducted in compliance with U.S. Environmental Protection Agency Good Laboratory Practice (GLP) which stated that I2Cure demonstrates virucidal activity against SARS-Related Coronavirus 2 as compared to the 30-second exposure virus control which makes it effective against COVID.

FDA has also defined persistence of I2cure as a microbicidal activity over a 6 hour time period in the test reports. The report claims that at and after application of I2cure, for 6 hours, the virus is completely DEAD which makes the product 99.9% effective against COVID-19.

The test and study was done to determine the minimum virucidal activity against SARS-Related Coronavirus 2 virus of a chemical disinfectant in contact with medical instruments, surfaces or hands, according to the method BS EN 14476 by CEN (European Committee for Standardization). It was also to determine the activity of chemical disinfectants that form a homogeneous, physically stable preparation in hard water – or in the case of ready-to-use products – with distilled water, and in the conditions in which they are used.

“I2Cure stands apart from other quick-fix topical disinfectants like alcohol-based sanitizers as it provides iodine protection to the skin. I2cure is absorbed in the skin releasing a vapour which builds a protective shield and acts as antimicrobial material up to 6 hours”, says Dr. Kessler, Inventor, I2cure.

Unlike the alcohol-based sanitizers, I2Cure provides 12-hour, fool-proof protection against viral, bacterial, and fungal threats. Moreover, iodine nourishes and hydrates the skin as opposed to dry and cracked skin from alcohol-based products. As molecular iodine is the active agent in I2Cure, it has the ability to enter your skin, leaving no stain or smell. This prevents it from being washed away or rubbed off.

There have been several studies which stated that iodine is effective against COVID-19. Povidone-iodine which has been introduced to the market has only about 5-10 part per million of active molecular iodine and the rest is all junk. Dr. Kessler has developed a method to stabilize molecular iodine which is 100 times more effective and powerful than povidone-iodine. Not only is this molecular iodine-based I2cure is providing protection against covid, but is effective against all bacteria, fungal, viral infection, tuberculosis, TInea and all kinds of skin diseases.

I2Cure is a bio-shield antiseptic lotion and an easy, single-use broad-spectrum antimicrobial that provides the protection of iodine against COVID-19. It is the first company in the world to provide molecular Iodine based ‘Bio Shield’, a deep cleaning hand lotion that is not just effective and safe, but also provides nourishment to the human skin. I2cure is going to be a magic drug of the future and will be taken across the globe.